Kestra Medical Technologies (KMTS) Competitors $16.03 +1.00 (+6.65%) As of 03:52 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock KMTS vs. LIVN, WRBY, INSP, PRCT, LMAT, EYE, AORT, LQDA, CNMD, and ENOVShould you be buying Kestra Medical Technologies stock or one of its competitors? The main competitors of Kestra Medical Technologies include LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), LeMaitre Vascular (LMAT), National Vision (EYE), Artivion (AORT), Liquidia Technologies (LQDA), CONMED (CNMD), and Enovis (ENOV). These companies are all part of the "medical equipment" industry. Kestra Medical Technologies vs. Its Competitors LivaNova Warby Parker Inspire Medical Systems PROCEPT BioRobotics LeMaitre Vascular National Vision Artivion Liquidia Technologies CONMED Enovis LivaNova (NASDAQ:LIVN) and Kestra Medical Technologies (NASDAQ:KMTS) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, dividends, media sentiment, institutional ownership, risk and earnings. Do analysts rate LIVN or KMTS? LivaNova presently has a consensus price target of $59.29, suggesting a potential upside of 11.73%. Kestra Medical Technologies has a consensus price target of $27.33, suggesting a potential upside of 70.51%. Given Kestra Medical Technologies' higher probable upside, analysts clearly believe Kestra Medical Technologies is more favorable than LivaNova.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LivaNova 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.00Kestra Medical Technologies 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 Does the media favor LIVN or KMTS? In the previous week, LivaNova had 19 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 21 mentions for LivaNova and 2 mentions for Kestra Medical Technologies. Kestra Medical Technologies' average media sentiment score of 0.94 beat LivaNova's score of 0.60 indicating that Kestra Medical Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LivaNova 5 Very Positive mention(s) 3 Positive mention(s) 11 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Kestra Medical Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals hold more shares of LIVN or KMTS? 97.6% of LivaNova shares are held by institutional investors. 0.3% of LivaNova shares are held by company insiders. Comparatively, 3.6% of Kestra Medical Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has preferable earnings and valuation, LIVN or KMTS? LivaNova has higher revenue and earnings than Kestra Medical Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLivaNova$1.25B2.31$63.23M-$3.89-13.64Kestra Medical Technologies$59.81M13.76-$113.81MN/AN/A Is LIVN or KMTS more profitable? Kestra Medical Technologies has a net margin of 0.00% compared to LivaNova's net margin of -16.13%. LivaNova's return on equity of 14.57% beat Kestra Medical Technologies' return on equity.Company Net Margins Return on Equity Return on Assets LivaNova-16.13% 14.57% 6.91% Kestra Medical Technologies N/A N/A N/A SummaryLivaNova beats Kestra Medical Technologies on 9 of the 14 factors compared between the two stocks. Get Kestra Medical Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for KMTS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KMTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KMTS vs. The Competition Export to ExcelMetricKestra Medical TechnologiesMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$771.77M$10.54B$5.55B$9.83BDividend YieldN/A1.97%4.62%4.11%P/E RatioN/A20.0630.1526.03Price / Sales13.7624.84460.84104.94Price / CashN/A24.0537.7558.93Price / Book4.013.138.476.06Net Income-$113.81M$209.94M$3.26B$265.11M7 Day Performance10.86%8.82%3.56%2.90%1 Month Performance7.51%9.93%5.97%3.99%1 Year PerformanceN/A-6.89%42.70%26.92% Kestra Medical Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KMTSKestra Medical Technologies1.2952 of 5 stars$16.03+6.7%$27.33+70.5%N/A$771.77M$59.81M0.00300LIVNLivaNova2.0474 of 5 stars$49.55+2.1%$59.29+19.6%+16.7%$2.70B$1.25B-12.732,900Earnings ReportWRBYWarby Parker2.0167 of 5 stars$23.58+0.4%$23.88+1.3%+87.6%$2.47B$771.32M-196.583,780Insider TradeINSPInspire Medical Systems4.7152 of 5 stars$79.51+3.2%$173.31+118.0%-56.9%$2.35B$802.80M45.961,246Positive NewsBuyback AnnouncementPRCTPROCEPT BioRobotics3.2904 of 5 stars$38.58-2.6%$74.88+94.1%-39.0%$2.13B$274.95M-24.89430Positive NewsEarnings ReportAnalyst RevisionLMATLeMaitre Vascular2.1926 of 5 stars$92.64-1.7%$98.00+5.8%+15.0%$2.09B$234.64M44.98490Insider TradeEYENational Vision3.0343 of 5 stars$22.68-6.2%$24.73+9.1%+123.2%$1.79B$1.82B-126.0813,411Positive NewsEarnings ReportAORTArtivion2.9591 of 5 stars$40.64+24.3%$38.80-4.5%+73.9%$1.74B$388.54M-81.271,600Earnings ReportAnalyst ForecastHigh Trading VolumeLQDALiquidia Technologies3.0063 of 5 stars$20.18+5.0%$26.89+33.2%+97.4%$1.73B$14M-12.8350Trending NewsEarnings ReportAnalyst ForecastOptions VolumeGap UpCNMDCONMED3.9587 of 5 stars$54.67+2.4%$59.80+9.4%-18.1%$1.69B$1.31B15.493,900News CoverageDividend AnnouncementENOVEnovis4.3283 of 5 stars$28.80+1.0%$51.83+80.0%-32.2%$1.65B$2.11B-2.067,367News CoverageEarnings ReportAnalyst Revision Related Companies and Tools Related Companies LIVN Alternatives WRBY Alternatives INSP Alternatives PRCT Alternatives LMAT Alternatives EYE Alternatives AORT Alternatives LQDA Alternatives CNMD Alternatives ENOV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KMTS) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kestra Medical Technologies, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kestra Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access